Darling Ingredients Inc. Stock 12‑Month Price Target Raised to $79.07, Implies 35% Upside
Less than 1 min read According to estimates from 14 analysts, Darling Ingredients Inc. stock's average price target has risen from $78.29 to $79.07, with forecasts ranging from $62 to $100 per share Based on the Jul. 29 closing price, the updated target implies approximately 35% potential upside Consensus rating remains at “Buy” across 15 covering analysts, with 14 Buys, 1 Holds and 0 Sells Explore more price target data and ratings for Darling Ingredients Inc.
How this was made

The 30-second read
Why it matters
Consensus target increased slightly and the rating remains “Buy,” which is incremental sentiment support but not a standalone catalyst.
Market read
Traders may view the target lift as mild bullish sentiment, but the lack of new company fundamentals limits trading edge.
What to watch
The article provides no thesis for the target change, no changes to earnings estimates, and no mention of revisions to near-term guidance or margins.
Background
The piece summarizes FactSet consensus analyst estimates for Darling Ingredients’ 12-month price target and rating distribution.
Ticker impact
Darling Ingredients’ average 12-month analyst price target rose from $78.29 to $79.07, implying about 35% upside from the Jul. 29 close.
Modest upward bias possible if traders treat the target lift as incremental bullishness; likely limited follow-through without new operating or guidance data.
The only disclosed change is the FactSet-derived consensus target and unchanged “Buy” rating mix, with no new earnings, guidance, or company-specific catalyst.
Market effects
Limited sector read-through because the update is purely analyst-target related with no new industry datapoint.
None indicated.
None indicated.
Counterpoint
A higher average target can reflect model recalibration rather than improved fundamentals, so it may not sustain price action.
Key entities
- public_companyDarling Ingredients Inc.
Subject of the article; consensus 12-month price target raised to $79.07 and implied upside cited.


